CLASS II ONGOING Device recall · Reported 7 Jul 2021 · FDA Enforcement Report

Tempus Pro - Patient physiological monitor recalled

Remote Diagnostic Technologies is recalling Tempus Pro - Patient physiological monitor, arrhythmia detector and alarm, distributed nationwide in the US. The recall was initiated on 25 May 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version number: v07.00, v07.01, v07.18, v07.20, v07.22, v07.24. UDI No. 12NC No. 05060472440020 989706002081 05060472440013 989706000001 05060472441027 989706000051 05060472441058 989706000101
Quantity recalled510 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1997-2021
FDA event ID
88051
Recalling firm
Remote Diagnostic Technologies, Basingstoke, N/A
Classification
Class II
Status
Ongoing
Recall initiated
25 May 2021
FDA classified
1 Jul 2021
Reported
7 Jul 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

25 May 2021Recall initiated by company
1 Jul 2021Classified by FDA+37 days
7 Jul 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Tempus Pro (Trizeps 7 only) when used in combination with a specified laryngoscope device can cause two error types when subsequently unplugged.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Tempus Pro - Patient physiological monitor, arrhythmia detector and alarm. Part No. - 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R. Product Usage: intended to be used as a stand-alone monitor or as a telemedicine system (transmitting patient data to other medical professionals located elsewhere).

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of FL, TX, PA, MN, UT, MT, CA, WI, VA, NY, TN, KS, MD and the countries of Australia, Austria, Czech Republic, France, Germany, Hong Kong, Israel, Italy, Netherlands, Thailand, Abu Dhabi, UK.

Nationwide CaliforniaFloridaKansasMarylandMinnesotaMontanaNew YorkPennsylvaniaTennesseeTexasUtahVirginiaWisconsin

Questions about this recall

Why was it recalled?

The Tempus Pro (Trizeps 7 only) when used in combination with a specified laryngoscope device can cause two error types when subsequently unplugged.

Which lots are affected?

Software version number: v07.00, v07.01, v07.18, v07.20, v07.22, v07.24. UDI No. 12NC No. 05060472440020 989706002081 05060472440013 989706000001 05060472441027 989706000051 05060472441058 989706000101

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of FL, TX, PA, MN, UT, MT, CA, WI, VA, NY, TN, KS, MD and the countries of Australia, Austria, Czech Republic, France, Germany, Hong Kong, Israel, Italy, Netherlands, Thailand, Abu Dhabi, UK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Remote Diagnostic Technologies

All 12

Other Patient Monitors recalls

All 1,022